La pagina è disponibile in più lingue
Select Language

Fine Foods passa da AIM Italia a STAR di Borsa Italiana


  • Terzo passaggio dell’anno sul segmento STAR di Borsa Italiana
  • Fine Foods & Pharmaceuticals N.T.M. S.p.A. porta a 80 il numero delle società quotate sul segmento STAR

Milano – 12 luglio 2021 – Fine Foods & Pharmaceuticals N.T.M. S.p.A. passa oggi da AIM Italia al segmento STAR di Borsa Italiana, parte del Gruppo Euronext.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. è una CDMO (Contract Development & Manufacturing Organization) italiana indipendente che sviluppa e produce in conto terzi prodotti per l'industria farmaceutica e nutraceutica.

Fine Foods & Pharmaceuticals N.T.M. S.p.A., quotata su AIM Italia nell’ottobre 2018, rappresenta la dodicesima società che effettua un passaggio di mercato da AIM Italia al Segmento STAR di Borsa Italiana e porta a 80 il numero di società attualmente quotate sul segmento STAR.

Marco Francesco Eigenmann, Presidente e CEO di Fine Foods & Pharmaceuticals N.T.M. S.p.A., ha detto: "Il passaggio al segmento STAR rientra tra gli obiettivi che Fine Foods si era prefissata già in fase di quotazione su AIM Italia e oggi possiamo affermare di aver mantenuto l’impegno preso nei confronti del mercato. Sono sicuro che tale passaggio ci permetterà di creare nuove opportunità di crescita sia organica che per linee esterne e di accedere ad una sempre più ampia platea di investitori, italiani e internazionali. Ci piace comunque considerare questo traguardo come un nuovo punto di partenza per generare ulteriore valore per tutti i nostri stakeholder, forti del nostro modello di business da sempre contraddistinto da un approccio olistico all’ESG, fondato su una solida Governance, un’impareggiabile struttura R&D e una passione per l’innovazione. A nome di tutta Fine Foods, ringrazio Borsa Italiana che ci ha assistito e supportato in questo importantissimo progetto. Ringrazio anche i nostri consulenti, i nostri dipendenti e tutti coloro che hanno reso possibile questa operazione".

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Fine Foods & Pharmaceuticals N.T.M. S.p.A. is an Italian independent CDMO (Contract Development and Manufacturing Organisation). It develops and manufactures contract products for the pharmaceutical and nutraceutical industry; the Fine Foods Group is also active in the cosmetics, biocides and medical devices industries with its recent acquisition of Pharmatek-PMC. Founded in 1984, from a pharmaceutical and nutraceutical synergy, Fine Foods has been pursuing quality and innovation on behalf of its customers as its primary objective. With €172 million in revenue in 2020 and an 11% CAGR over the last decade, it is a growing and future-oriented company. The sustainability of the business model and the holistic approach to ESG, together with product innovation, are drivers that will allow the Group to fully develop its intrinsic potential.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter ( and LinkedIn (

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at

© 2023, Euronext N.V. - All rights reserved.